(NYXH - NYXOAH SA)

company profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Nyxoah (NYXH) is trading at 3.07

Open Price
3.21
Previous close
3.07
Previous close
3.07
P/E Ratio
0
Sector
Health Care
Shares outstanding
43662403
Primary exchange
NASDAQ-NMS
ISIN
BE0974358906